These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

411 related items for PubMed ID: 15803885

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Clinical review 51: Implications of the Diabetes Control and Complications Trial.
    Eastman RC, Siebert CW, Harris M, Gorden P.
    J Clin Endocrinol Metab; 1993 Nov; 77(5):1105-7. PubMed ID: 8077299
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. DCCT: implications for diabetes care in the UK.
    Boulton AJ.
    Diabet Med; 1993 Oct; 10(8):687. PubMed ID: 8261748
    [No Abstract] [Full Text] [Related]

  • 10. Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients.
    Shichiri M, Kishikawa H, Ohkubo Y, Wake N.
    Diabetes Care; 2000 Apr; 23 Suppl 2():B21-9. PubMed ID: 10860187
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Reviewing statin therapy in diabetes--towards the best practise.
    Matikainen N, Kahri J, Taskinen MR.
    Prim Care Diabetes; 2010 Apr; 4(1):9-15. PubMed ID: 20171948
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cost-effectiveness of intensive insulin therapy for type 2 diabetes: a 10-year follow-up of the Kumamoto study.
    Wake N, Hisashige A, Katayama T, Kishikawa H, Ohkubo Y, Sakai M, Araki E, Shichiri M.
    Diabetes Res Clin Pract; 2000 Jun; 48(3):201-10. PubMed ID: 10802159
    [Abstract] [Full Text] [Related]

  • 17. NMDAR antagonists for the treatment of diabetes mellitus-Current status and future directions.
    Welters A, Klüppel C, Mrugala J, Wörmeyer L, Meissner T, Mayatepek E, Heiss C, Eberhard D, Lammert E.
    Diabetes Obes Metab; 2017 Sep; 19 Suppl 1():95-106. PubMed ID: 28880473
    [Abstract] [Full Text] [Related]

  • 18. Fields of application of continuous subcutaneous insulin infusion in the treatment of diabetes and implications in the use of rapid-acting insulin analogues.
    Pitocco D, Rizzi A, Scavone G, Tanese L, Zaccardi F, Manto A, Ghirlanda G.
    Minerva Endocrinol; 2013 Sep; 38(3):321-8. PubMed ID: 24126552
    [Abstract] [Full Text] [Related]

  • 19. Diabetes complications. Proactive care a must.
    Mayo Clin Health Lett; 2012 Oct; 30(10):4-5. PubMed ID: 23133856
    [No Abstract] [Full Text] [Related]

  • 20. Workshop VIII--Retinopathy, nephropathy, neuropathy, and tight control.
    Lebovitz HE, Vinik AI.
    Am J Med; 1991 Feb 21; 90(2A):80S-84S. PubMed ID: 1994725
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.